Skip to content

Access Sheath and Stent Trial

Access Sheath and stENT Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07297953
Acronym
ACCENT
Enrollment
184
Registered
2025-12-22
Start date
2025-09-24
Completion date
2026-10-31
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stone, Ureteral Stone

Keywords

Ureteral stent, Ureteroscopy and lithotripsy, Surveys, Quality of life

Brief summary

The study is being completed to compare patient reported outcomes for stent omission vs. placement after using a ureteral access sheath for uncomplicated ureteroscopy. Participants that consent for the study will complete baseline PRO questionnaires. A UAS will be used during surgery, and the size left to the discretion of the surgeon. At the end of the procedure, the urologist will evaluate the ureter for iatrogenic injury, and the ureter will be graded using the Post Ureteroscopic Lesion Scale (PULS). Patients assessed with PULS 0 and PULS 1 will meet 2nd stage eligibility and will be randomized 1:1 to either stent omission or stent placement. When a stent is placed, the stent type and decision to leave a string (tether) will be at the operating urologist's discretion. Hypothesis: \- stent omission arm will be non-inferior to stent placement in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference and Pain Intensity, and have lower 30-day healthcare utilization.

Interventions

OTHERSurveys

Surveys will be completed for each group at the following timeframes: baseline (pre-procedure, daily up to 7-10 days or until stent is removed (if placed), 30 days after the procedure. Additionally, participants medical records will reviewed for information.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Masking description

Patients will be informed of the presence or absence of a stent immediately following participants surgery.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Planned ureteroscopy using a Ureteral Access Sheath (UAS) for treatment of unilateral kidney and/or ureteral stones in patients that have an existing ureteral stent (pre-stented) * Planned treatment of unilateral renal and/or ureteral stones, in a single procedure. * Renal stone defined as only renal location of stone(s) * Ureteral stone defined as ureteral only location of stone(s) * Ureteral and renal stone(s) * No evidence of significant ureteral injury on intra-operative assessment (Post-Ureteroscopy Lesion Scale (PULS) Grade 0 or 1) * Ability and willingness to complete and adhere to survey questions and responses throughout study duration.

Exclusion criteria

* Pregnancy * Ureteric injury during ureteroscopy (PULS ≥ Grade 2) * Evidence of ureteral stricture * Anatomical abnormalities (e.g., solitary, horseshoe, fused crossed ectopia, pelvic kidney, urinary diversion) * Known planned secondary or staged procedure * Indwelling nephrostomy tube * Bilateral ureteroscopy

Design outcomes

Primary

MeasureTime frameDescription
Differences in PROMIS Pain InterferenceBaseline (before procedure), 7-10 days after procedureThis is a 6-item survey which participants select a response for each item from 1=not at all to 5=very much for how much pain interfered with their life. The scores range from 6-30 with a higher score indicating greater interference.

Secondary

MeasureTime frameDescription
Differences in Urinary Symptoms based on the Lower Urinary Tract Dysfunction Research Network (LURN) Symptom index (SI)-107-10 days after procedureThe LURN SI-10 (10-Item LURN Symptom Index) assesses urinary frequency, nocturia, urgency, incontinence, bladder pain, voiding and post-micturition symptoms. Responses for each item range from 0 to 4 or 0 to 3 and are then summed for total scores ranging from 0 to 38 (higher scores = worse symptoms/bother).
Difference in PROMIS Social Roles & ActivitiesDaily after procedure (10 days or up to stent removal)This is one question from the PROMIS that participants select from Never (5) to Always (1) whether there is trouble doing all of participant's usual work. A lower score indicates more trouble.
Difference in Pain intensity assessment based on the Visual analog scaleDaily after procedure (10 days or up to stent removal)Participants pain level is selected from 0-10 with a higher score indicating greater pain.
Treatment Satisfaction based on the International Consultation on Incontinence Questionnaire Short Form (ICIQ-S)7-10 days post procedure and 4 weeksThis is a 6-item questionnaire that participants complete regarding the satisfaction with treatment. The range of scores for each question is between 0-5, with a range of score between 0-24 with a higher score indicating greater satisfaction.
Count of days off work PatientDay 7 post procedure and 4 weeks post procedure
Differences in PROMIS Pain intensity7-10 days after procedureThis is a 3-item survey which participants select a response for each item from 1=no pain to 5=very severe for intensity of their pain. The scores range from 3-15 with a higher score indicating greater pain intensity.
Composite healthcare utilization metric within 30 days (WinRatio)Up to 30 days after procedureWinRatio composite healthcare utilization score ranges from 1 to 6 based on each participants highest level of healthcare utilization, with higher score indicating a worse outcome: 6) Hospitalization and ICU care; 5) Unplanned hospitalization; 4) Additional OR or Interventional Radiology procedure 3) Emergency department visit; 2) Ambulatory encounter: clinic visit or diagnostic outpatient testing; 1) Ambulatory encounter: phone call or electronic medical record.
Abnormal imaging findings within 60 dayswithin 60 days of procedureUrological imaging performed within 60 days per surgeon or patient preference.
Stone-free rates within 60 dayswithin 60 days of procedureX-ray, Ultrasound, computerized tomography (CT) scan, or any combination
Differences in PROMIS Pain Interference4-6 weeks after procedureThis is a 6-item survey which participants select a response for each item from 1=not at all to 5=very much for how much pain interfered with their life. The scores range from 6-30 with a higher score indicating greater interference.
Count of days off work CaregiverDay 7 post procedure and 4 weeks post procedure

Countries

United States

Contacts

Primary ContactMUSIC Coordinating Center
esekulos@med.umich.edu734-232-4906

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026